Microvascular Complications Associated with Advanced Glycation End Products in Diabetes

References (41)

1. 1 Mechanisms of Diabetic Complications [DOI]
2. 2 Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus [DOI]
3. 3 Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting [DOI]
4. 4 The wanderings of a free radical [DOI]
5. 5 A Perspective on the Maillard Reaction and the Analysis of Protein Glycation by Mass Spectrometry: Probing the Pathogenesis of Chronic Disease [DOI]
6. 6 Glucose handling by the kidney [DOI]
7. 7 Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. [DOI]
8. 8 The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review [DOI]
9. 9 Association of Metformin, Elevated Homocysteine, and Methylmalonic Acid Levels and Clinically Worsened Diabetic Peripheral Neuropathy [DOI]
10. 10 The Role of Advanced Glycation End Products in Diabetic Vascular Complications [DOI]
11. 11 Diabetic Painful and Insensate Neuropathy: Pathogenesis and Potential Treatments [DOI]
12. 12 Endogenous advanced glycation end products in the pathogenesis of chronic diabetic complications [DOI]
13. 13 Diabetes and retinal vascular dysfunction. [DOI]
14. 14 Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study [DOI]
15. 15 The Role of Advanced Glycation End Products in Retinal Microvascular Leukostasis [DOI]
16. 16 Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy [DOI]
17. 17 The Mechanisms of Inhibition of Advanced Glycation End Products Formation through Polyphenols in Hyperglycemic Condition [DOI]
18. 18 Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis [DOI]
19. 19 Effects of Exogenous Dietary Advanced Glycation End Products on the Cross-Talk Mechanisms Linking Microbiota to Metabolic Inflammation [DOI]
20. 20 Advanced-Glycation End-Products Induce Podocyte Injury and Contribute to Proteinuria [DOI]
21. 21 Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease [DOI]
22. 22 Serum Levels of sRAGE, the Soluble Form of Receptor for Advanced Glycation End Products, Are Associated with Inflammatory Markers in Patients with Type 2 Diabetes [DOI]
23. 23 Inhibitory effects of Nelumbo nucifera leaves on rat lens aldose reductase, advanced glycation endproducts formation, and oxidative stress [DOI]
24. 24 Antioxidants in the Prevention and Treatment of Diabetic Retinopathy – A Review [DOI]
25. 25 Phytochemicals against anti‐diabetic complications: targeting the advanced glycation end product signaling pathway [DOI]
26. 26 A Review of Recent Investigations on Medicinal Herbs Possessing Anti-Diabetic Properties [DOI]
27. 27 Effects of Moderate Intensity Physical Training in Neonatal Alloxan- Administered Rats [DOI]
28. 28 Health and Knowledge Progress among Diabetic Patients after Implementation of a Nursing Care Program Based on Their Profile [DOI]
29. 29 Spectrum of Autoimmune Disorders in Type 1 Diabetes – A Cross-Sectional Clinical Audit [DOI]
30. 30 A Review on Diabetes Mellitus: Complications, Management and Treatment Modalities
31. 31 Advanced Glycation End Products: Formation, Role in Diabetic Complications, and Potential in Clinical Applications [DOI]
32. 32 Obesity Indices amongst Diabetics in an Urban Population of Western Nepal [DOI]
33. 33 Assessment of Weight Loss in the Management of Patients with Type 2 Diabetes Mellitus in Primary Care in Trinidad [DOI]
34. 34 A Review of Recent Investigations on Medicinal Herbs Possessing Anti-Diabetic Properties [DOI]
35. 35 Reversal of Metabolic Dysfunction through Polyvalent Pharmacotherapyaugmented Lifestyle Intervention: Case Reports [DOI]
36. 36 Maillard reaction and immunogenicity of protein therapeutics [DOI]
37. 37 Possible Association between Keratoconus and Renal Diseases [DOI]
38. 38 Association of Advanced Glycation End Products (AGEs) with Diabetic Nephropathy and Alcohol Consumption [DOI]
39. 39 The Proceedings of the National Academy of Sciences [DOI]
40. 40 Oxidative Medicine and Cellular Longevity [DOI]
41. 41 Diabetes/Metabolism Research and Reviews [DOI]

Cited by 7

Showing 3 of 7 known citations — external sources report more than can currently be individually listed.

Related research

• The Protective Effect of Pomegranate (Punica granatum) against Oxidative Stress and Nephropathy Induced by Diabetes in Male Rats: A Biochemical, Molecular and Histopathological Study — shares topic coverage
• Interleukin 10 Gene Polymorphisms and Susceptibility to Nephropathy in Egyptian Diabetic Patients — shares topic coverage
• TNF-α (-308 G→A) Polymorphism and the Risk of Progression to End Stage Renal Disease in Nephropathy Patients — shares topic coverage
• Antioxidant Status and Anti-inflammatory Effects of Oleuropein in Streptozotocin-induced Diabetic Nephropathy in Rats — shares topic coverage
• Progression of Albuminuria in Sickle Cell Disease at the Clinical Hematology Department in Abidjan — shares topic coverage